Mirae Asset Global ETFs Holdings’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,114
Closed -$52.1K 3266
2026
Q1
$52.1K Buy
5,114
+136
+3% +$1.47K ﹤0.01% 2896
2025
Q4
$53.2K Sell
4,978
-238
-5% -$2.85K ﹤0.01% 2919
2025
Q3
$71.3K Sell
5,216
-1,012
-16% -$14.1K ﹤0.01% 2820
2025
Q2
$87.5K Sell
6,228
-278
-4% -$3.65K ﹤0.01% 2676
2025
Q1
$87.7K Buy
6,506
+291
+5% +$4.37K ﹤0.01% 2692
2024
Q4
$110K Buy
6,215
+263
+4% +$4.88K ﹤0.01% 2666
2024
Q3
$114K Buy
5,952
+1,071
+22% +$20.6K ﹤0.01% 2656
2024
Q2
$107K Buy
+4,881
New +$130K ﹤0.01% 2536

Other funds holding MED

Mirae Asset Global ETFs Holdings's MED Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Medifast (MED) in Q2 2026, closing a stake of 5,114 shares — an estimated $52.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in MED in Q2 2024 and held it in 8 quarters. The position peaked at $114K in Q3 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 5,114 Medifast shares in Q2 2026, an estimated $52.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Medifast in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Medifast position peaked at $114K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.